<DOC>
	<DOCNO>NCT00039650</DOCNO>
	<brief_summary>This study evaluate change T cells-infection-fighting white blood cell immune system-in people give drug call G-CSF donate stem cell ( immature bone marrow cell ) transplantation . Originally , bone marrow cell obtain use needle insert hipbone donor . However , discover immature bone marrow cell also circulate blood , scientist begin develop technique collect quantity cell blood instead bone . G-CSF blood cell growth factor push stem cell bone marrow bloodstream . Stem cell donor give drug 5 6 day donation make cell available circulate blood collection . Stem cell transplantation require careful regulation immune cell function allow donated stem cell grow transplant recipient , prevent transplant cell damage recipient , allow recipient 's new immune system develop normally fight infection . Studies compare outcome patient transplant bone marrow cell transplanted stem cell suggest G-CSF give stem cell donor affect function T cell transplant recipient . This study collect white cell contain T cell G-CSF administration determine effect drug T cell stem cell . Healthy normal volunteer 18 year age old meet health criterion donate blood may participate study . Pregnant breastfeed woman eligible . Participants undergo follow procedure : - Blood sample collection ( 15 milliliter , 3 teaspoon ) measure blood cell count - Electrocardiogram assess heart function - Apheresis donate white blood cell . Participants undergo two apheresis procedures-once receive G-CSF second time immediately finish 5-day course drug . For procedure , whole blood remove use needle place arm vein . The blood circulate cell separator machine , white cell remove collected plastic bag . The rest blood , include red cell , platelet , plasma , return donor needle arm . The procedure take 2 3 hour , time donor lie quietly .</brief_summary>
	<brief_title>Pilot Study : Effects G-CSF T Cell Function</brief_title>
	<detailed_description>T cell play critical role hematopoietic stem cell transplantation . Many transplant protocol involve HLA match sibling donor make use T cell mediate graft-versus-leukemia graft-versus-cancer effect clear and/or prevent recurrent growth malignant cell . Donor T cell also responsible reconstitute cellular immune function follow transplantation , often cause graft-versus-host disease ( GVHD ) . Over past several year major source hematopoietic stem cell transplantation change marrow granulocyte-colony stimulating factor ( G-CSF ) -mobilized peripheral blood stem cell ( PBSCs ) . Despite fact patient transplant allogeneic G-CSF-mobilized PBSCs receive approximately 10-fold T-cells transplant marrow , incidence severity acute GVHD similar among two group , although chronic GVHD high PBSC recipient . Using cellular function assay investigator show G-CSF affect T cell function . When healthy subject give G-CSF , decrease see concentration circulate type 1 helper T cell ( Th1 ) subsequent fall cytokine level produce cell . In contrast , increase occur concentration type 2 helper T cell ( TH2 ) level cytokine produce . The purpose study ass G-CSF-induced change T cell . cDNA microarrays use compare gene express CD4 CD8 cell G-CSF give . Up fifteen healthy subject give typical PBSC mobilization regimen allogeneic transplant : 10 micrograms/kg/day G-CSF 5 day . Peripheral blood mononuclear cell collect apheresis mobilization regimen give day mobilization complete . CD4 , CD8 , CD34+ cell isolated peripheral blood mononuclear cell gene expression assess use cDNA microarrays contain 8,000 gene .</detailed_description>
	<criteria>INCLUSION CRITERIA : Both male female subject study . Subjects enrol without regard ethnic group . Only adults child 18 year age old study . Subjects must weigh least 110 pound . EXCLUSION CRITERIA : Any subject pas health criterion blood donor establish American Association Blood Banks exclude . Subjects exclude follow condition : pregnancy , uncontrolled hypertension , heart disease , history allergic reaction GCSF , history allergic reaction E. coli , abnormal hemoglobin white blood cell count , malignancy , asthma . Subjects family member condition may require transplant future exclude . Subjects enlarge spleen history physical exam exclude . Subjects hemoglobin less 12.5 great 19.0 gm/dL , platelet count less 150 x 10 ( 9 ) /L great 500 x 10 ( 9 ) /L absolute neutrophil count le 1.5 x 10 ( 9 ) /L great 10.0 x 10 ( 9 ) /L eligible . Subjects abnormal EKG exclude study . Pregnant lactate woman exclude . If subject 's vein judge small support intravenous catheter require procedure , exclude . If time apheresis procedure nurse unable obtain adequate antecubital vein access , subject exclude .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2004</verification_date>
	<keyword>Granulocyte Colony-Stimulating Factor</keyword>
	<keyword>T Cells</keyword>
	<keyword>Peripheral Blood Stem Cells</keyword>
	<keyword>Apheresis</keyword>
	<keyword>Hematopoietic Progenitor Cell Transplantation</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>HV</keyword>
	<keyword>Normal Control</keyword>
</DOC>